Malignant pleural effusion: further translational research is crucial.
作者信息
Nishioka Yasuhiko
机构信息
Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, The University of Tokushima Graduate School, 3-18-15 Kuramoto-cho, Tokushima, 770-8503 Japan.
出版信息
Transl Lung Cancer Res. 2012 Sep;1(3):167-9. doi: 10.3978/j.issn.2218-6751.2012.09.06.
Abstract
摘要
相似文献
1
Malignant pleural effusion: further translational research is crucial.
Transl Lung Cancer Res. 2012 Sep;1(3):167-9. doi: 10.3978/j.issn.2218-6751.2012.09.06.
2
Diagnostic utility of CYFRA 21-1 in malignant pleural effusion.
Respirology. 2001 Sep;6(3):213-6. doi: 10.1046/j.1440-1843.2001.00332.x.
3
Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma.
Clin Chem Lab Med. 2011 Oct;49(10):1721-6. doi: 10.1515/CCLM.2011.242. Epub 2011 Jun 22.
4
Cytogenetic Study in Suspicious Cases of Malignant Pleural Effusion.
Cancer Res Treat. 2002 Jun;34(3):234-8. doi: 10.4143/crt.2002.34.3.234.
5
[Diagnostic value of soluble B7-H4 in malignant pleural effusion].
Zhonghua Yi Xue Za Zhi. 2012 Jan 10;92(2):117-8.
6
The diagnostic value of survivin in malignant pleural effusion: a meta-analysis.
Clin Chim Acta. 2015 Feb 20;441:142-7. doi: 10.1016/j.cca.2014.12.029. Epub 2015 Jan 3.
7
The utility of multi-detector computed tomography in the diagnosis of malignant pleural effusion in the patients with ovarian cancer.
Eur J Radiol. 2010 Aug;75(2):230-5. doi: 10.1016/j.ejrad.2009.04.061. Epub 2009 May 28.
8
[Value of detecting p16 gene methylation in the diagnosis of malignant pleural effusion].
Nan Fang Yi Ke Da Xue Xue Bao. 2010 Sep;30(9):2148-50.
9
The role of pleural fluid MAGE RT-nested PCR in the diagnosis of malignant pleural effusion.
Thorac Cancer. 2012 Nov;3(4):320-325. doi: 10.1111/j.1759-7714.2012.00131.x.
10
[Clinical value of tumor supplied group of factor combined with CEA in diagnosing tuberculosis pleural effusion and malignant pleural effusion].
Hunan Yi Ke Da Xue Xue Bao. 2003 Dec;28(6):608-10.
本文引用的文献
1
Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion.
Oncogene. 2013 Jan 24;32(4):528-35. doi: 10.1038/onc.2012.57. Epub 2012 Feb 27.
2
Antiresorptive therapies in oncology and their effects on cancer progression.
Cancer Treat Rev. 2012 Oct;38(6):776-86. doi: 10.1016/j.ctrv.2012.02.002. Epub 2012 Feb 26.
3
Multidisciplinary management of malignant pleural effusion.
J Surg Oncol. 2012 Jun 1;105(7):731-8. doi: 10.1002/jso.22100. Epub 2011 Sep 29.
4
What is the best treatment for malignant pleural effusions?
Interact Cardiovasc Thorac Surg. 2011 May;12(5):818-23. doi: 10.1510/icvts.2010.254789. Epub 2011 Feb 16.
5
Management of the patient with a malignant pleural effusion.
Semin Respir Crit Care Med. 2010 Dec;31(6):723-33. doi: 10.1055/s-0030-1269831. Epub 2011 Jan 6.
6
Host-derived interleukin-5 promotes adenocarcinoma-induced malignant pleural effusion.
Am J Respir Crit Care Med. 2010 Nov 15;182(10):1273-81. doi: 10.1164/rccm.201001-0001OC. Epub 2010 Jul 1.
7
Specific effects of bortezomib against experimental malignant pleural effusion: a preclinical study.
Mol Cancer. 2010 Mar 10;9:56. doi: 10.1186/1476-4598-9-56.
8
E7080, a multi-tyrosine kinase inhibitor, suppresses the progression of malignant pleural mesothelioma with different proangiogenic cytokine production profiles.
Clin Cancer Res. 2009 Dec 1;15(23):7229-37. doi: 10.1158/1078-0432.CCR-09-1980. Epub 2009 Nov 24.
9
A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
J Natl Cancer Inst. 2008 Oct 15;100(20):1464-76. doi: 10.1093/jnci/djn325. Epub 2008 Oct 7.
10
Advances in the systemic therapy of malignant pleural mesothelioma.
Nat Clin Pract Oncol. 2008 Mar;5(3):136-47. doi: 10.1038/ncponc1039.
Zotero 插件